Steven Reed - Feb 14, 2023 Form 4 Insider Report for Bellevue Life Sciences Acquisition Corp. (BLAC)

Role
Director
Signature
/s/ Steven Reed
Stock symbol
BLAC
Transactions as of
Feb 14, 2023
Transactions value $
$0
Form type
4
Date filed
2/16/2023, 07:05 PM
Previous filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLAC Common Stock Award $0 +20K $0.00 20K Feb 14, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLAC Warrant for Common Stock Award $0 +20K $0.00 20K Feb 14, 2023 Common Stock 20K $11.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the shares transferred by Bellevue Global Life Sciences Investors LLC (the "Sponsor"), the sponsor of the Issuer, to Mr. Reed for his board service.
F2 Represents the warrants to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Mr. Reed for his service as Chairman of the Board of Directors. Each warrant will become exercisable 30 days after the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination, or earlier upon redemption or liquidation. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustments.